Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 8, 1997, Pages 2653-2659

  Al Shoumer, Kamal A S ^a,b   Cox, Katharine H ^a   Hughes, Carol L ^a   Richmond, William ^a   Johnston, Desmond G ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b NONE   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCORTISONE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SEX HORMONE; THYROXINE; TRIACYLGLYCEROL;

ADULT; AREA UNDER THE CURVE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPOPITUITARISM; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR DISEASE;

ADULT; AGED; APOLIPOPROTEIN A-I; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FASTING; FEMALE; FOOD; GONADAL STEROID HORMONES; HUMAN GROWTH HORMONE; HUMANS; HYDROCORTISONE; HYPOPITUITARISM; LIPIDS; LIPOPROTEIN(A); MALE; MIDDLE AGED; THYROXINE; TRIGLYCERIDES;

EID: 0030790213     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.8.2653     Document Type: Article

References (42)

1. Rosén T, Bengtsson B-Å. 1990 Premature cardiovascular mortality in hypopituitarism: a study of 333 consecutive patients. Lancet. 336:285-288.
2. Wüster C, Slenczka E, Ziegler R. 1991 Erhöhte Prälvalenz von Osteoprose und Arteriosklerose bei konventionell substituierter hypophysenvorderlappen Insuffizienz. Bedraf einer zusätzlichen Wachstumshormonsubstitution? Klin Wochenschr. 68:769-773.
3. Markussis V, Beshyah SA, Fisher C, Sharp P, Nicolaides AN, Johnston DG. 1992 Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet. 340:1188-1192.
4. Shahi M, Beshyah S, Hackett D, Sharp P, Johnston D G, Foale RA. 1992 Myocardial function in treated adult hypopituitarism: a possible explanation for increased cardiovascular mortality. Br Heart J. 67:92-96.
5. Sacca L, Cittadini A, Fazio S. 1994 Growth hormone and the heart. Endocr Rev. 15:555-573.
6. Havel RJ. 1988 Lowering cholesterol. Rationale, mechanism and means. J Clin Invest. 81:1653-1660.
7. Lindenstrom E, Boysen G, Nyboe J. 1994 Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen city heart study. Br Med J. 309:11-15.
8. Zilversmit DB. 1979 Atherogenesis: a postprandial phenomenon. Circulation. 611:473-485.
9. Groot PHE, van Stiphout WAHJ, Krauss XH, et al. 1991 Post-prandial lipoprotein metabolism in normolipidaemic men with and without coronary artery disease. Arterioscler. Thromb. 11:653-662.
10. Patsch JR, Miesenböck G, Hopferwieser T, et al. 1992 Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb. 12:1336-1345.
11. Merimee TJ, Hollander W, Fineberg SE. 1972 Studies of hyperlipidemia in the HGH-deficient state. Metabolism. 21:1053-1061.
12. Libber SM, Plotnick LP, Johanson AJ, Blizzard RM, Kwiterovich PO, Migeon CJ. 1990. Long-term follow-up of hypopituitary patients treated with human growth hormone. Medicine. 69:46-55.
13. DeBoer H, Blok GJ, Voerman HJ, Philips M, Schouten JA. 1994 Serum lipids in growth hormone deficient men. Metabolism. 43:199-203.
14. Al-Shoumer KAS, Ali K, Anyaoku V, Niththyananthan R, Johnston DG. 1996 Overnight metabolic fuel deficiency in patients treated conventionally for hypopituitarism. Clin Endocrinol (Oxf). 45:171-178.
15. Beshyah SA, Henderson A, Niththyananthan R, Sharp P, Richmond W, Johnston DG. 1994 Metabolic abnormalities in growth hormone deficient adults. II. Carbohydrate tolerance and lipid metabolism. Endocrinol Metab. 1:173-180.
16. +2 precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem. 28:1379-1388.
17. Teale JD, Marks V. 1986 The measurement of insulin like growth factor I: clinical applications and significance. Ann Clin Biochem. 23:413-424.
18. Bates AS, Hoff WV, Jones PJ, Clayton RN. 1996 The effects of hypopituitarism on life expectancy. J Clin Endocrinol Metab. 81:1169-1172.
19. Erfurth EM, Bülow B, Mikozy Z, Nordström C-H, Hagmar L. 1996 Increased cardiovascular mortality in patients with hypopituitarism. Endocrinol Metab. 3(Suppl A):121.
20. Kirchmair R, Ebenbichler CF, Patsch JR. 1995 Post-prandial lipaemia. Baillieres Clin Endocrinol Metab. 9:705-719.
21. National Cholesterol Education Program. 1994 Second report of the expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Circulation. 89:1329-1445.
22. Pollare T, Bessby B, Lithell H. 1991 Lipoprotein lipase activity in skeletal muscle is related to insulin sensitivity. Arterioscler Thromb. 11:1192-1203.
23. Chen Y-DI, Facchini F, Landau C, Hollenbeck CB, Reaven GM. 1994 Plasma post-heparin lipoprotein lipase activity is decreased in normal individuals who are resistant to insulin-mediated glucose uptake. Endocrinol Metab. 1:153-158.
24. Asayama K, Amemiya S, Kusano S, Kato K. 1984 Growth-hormone-induced changes in postheparin plasma lipoprotein lipase and hepatic triglyceride lipase activities. Metabolism. 33:129-131.
25. Beshyah SA, Henderson A, Baynes C, Copping D, Richmond W, Johnston DG. 1995 Post-heparin plasma lipase activity in hypopituitary adults. Horm Res. 44:69-74.
26. Cuneo RC, Salomon F, Watts GF, Hesp R, Sönksen PH. 1993 Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency. Metabolism. 42:1519-1523.
27. Friedman M, Byers SO, Elek SR. 1970 Pituitary growth hormone is essential for regulation of serum cholesterol. Nature. 225:464-467.
28. White R, Schaefer EJ, Papadopoulos NM. 1983 The effect of growth hormone administration on lipids and lipoproteins in growth hormone deficient patients. Proc Soc Exp Biol Med. 173:63-67.
29. Salomon F, Cuneo RC, Hesp R, Sönksen PH. 1989 The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med. 321:1797-1803.
30. Binnerts A, Swart GR, Wilson JH, et al. 1992 The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as body composition. Clin Endocrinol (Oxf). 37:79-87.
31. Russell-Jones DL, Watts GF, Weissberger A, et al. 1994 The effect of growth hormone replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult growth hormone deficient patients. Clin Endocrinol (Oxf). 41:345-350.
32. Garry P, Collins P, Devlin JG. 1996 An open 36-month study of lipid changes with growth hormone in adults: lipid changes following replacement of growth hormone in adult acquired growth hormone deficiency. Eur J Endocrinol. 134:61-66.
33. Whitehead HM, Boreham C, McIlrath EM, et al. 1992 Growth hormone treatment of adults with growth hormone deficiency: results of 13-month placebo controlled cross over study. Clin Endocrinol (Oxf). 36:45-52.
34. Bengtsson B-Å, Eden S, Lonn L, et al. 1993 Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab. 76:309-317.
35. Rosén T, Johannsson G, Hallgren P, Caidahl K, Bosaeus I, Bengtsson B-Å. 1994 Beneficial effects of 12 months replacement with recombinant human growth hormone to growth hormone deficient adults. Endocrinol Metab. 1:55-66.
36. Angelin B, Rudling M. 1995 Growth hormone and lipoprotein metabolism. Endocrinol Metab. 2(Suppl B):25-28.
37. Rosén T, Edén S, Larsson G, Wilhelmsen L, Bengtsson B-Å. 1993 Cardiovascular risk factors in adult patients with growth hormone deficient. Acta Endocrinol (Copenh). 129:195-200.
38. O'Neal D, Hew FL, Sikaris K, Ward G, Alford F, Best JD. 1996 Low density lipoprotein particle size in hypopituitary adults receiving conventional hormone replacement therapy. J Clin Endocrinol Metab. 81:2448-2454.
39. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WS, Krauss RM. 1988 Low-density lipoprotein patterns and risk of myocardial infarction. JAMA. 260:1917-1921.
40. Brinton EA, Eisenberg S, Breslow JL. 1994 Human HDL-cholesterol levels are determined by Apo-A1 fractional catabolic rate, which correlates inversely with estimated HDL particle size. Arterioscler Thromb. 14:707-720.
41. Felig P, Bergman M. 1995 The endocrine pancreas: diabetes mellitus. In: Felig P, Baxter JD, Frohman LA, eds. Endocrinology and metabolism. New York: McGraw-Hill; 1107-1250.
42. 2 cholesterol. Metabolism. 36:949-952.